Florence Healthcare Supports Pfizer’s COVID-19 Vaccine Trials
Florence has announced a collaboration with Pfizer to support a global Phase II/III COVID-19 vaccine study. This extensive network of connectivity supports the COVID-19 trial by ensuring research can continue and thrive in a digital capacity, as onsite visits and collaboration are restricted due to the pandemic.
“We’re very proud to work with Pfizer on this vital trial,” says Ryan Jones, CEO of Florence. “It’s meaningful work to be able to support a company that’s at the forefront of innovation for the benefit of the global community. We will continue our support to help ensure Pfizer has everything it needs from a clinical trial software perspective to be successful.”
“Florence’s platform is helping us to respond to the changing environment due to COVID-19 and further progress COVID-19 research with the capability to perform remote monitoring where approved by regulatory authorities and ethics committees,” said Rob Goodwin, Vice President and Head of the Operations Center of Excellence in Global Product Development at Pfizer.
Read the full release, here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
